Cargando…
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
BACKGROUND: Lung cancer is the leading cause of cancer deaths worldwide. New diagnostics are needed to detect early stage lung cancer because it may be cured with surgery. However, most cases are diagnosed too late for curative surgery. Here we present a comprehensive clinical biomarker study of lun...
Autores principales: | Ostroff, Rachel M., Bigbee, William L., Franklin, Wilbur, Gold, Larry, Mehan, Mike, Miller, York E., Pass, Harvey I., Rom, William N., Siegfried, Jill M., Stewart, Alex, Walker, Jeffrey J., Weissfeld, Joel L., Williams, Stephen, Zichi, Dom, Brody, Edward N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999620/ https://www.ncbi.nlm.nih.gov/pubmed/21170350 http://dx.doi.org/10.1371/journal.pone.0015003 |
Ejemplares similares
-
Validation of a blood protein signature for non-small cell lung cancer
por: Mehan, Michael R, et al.
Publicado: (2014) -
Flu Hunter: Unlocking the Secrets of a Virus
por: Boktor, Sameh W., et al.
Publicado: (2019) -
Aptamer-based multiplexed proteomic technology for biomarker discovery
por: Gold, Larry, et al.
Publicado: (2010) -
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
por: Gold, Larry, et al.
Publicado: (2010) -
Early Detection of Malignant Pleural Mesothelioma in Asbestos-Exposed Individuals with a Noninvasive Proteomics-Based Surveillance Tool
por: Ostroff, Rachel M., et al.
Publicado: (2012)